Skip to content

An Experimental Study of SNT on Major Depresssive Disorder with childhood trauma

An Experimental Study of SNT on Major Depresssive Disorder with childhood trauma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124435
Enrollment
Unknown
Registered
2026-05-12
Start date
2026-01-22
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depresssive Disorder

Interventions

True stimulation group of depression patients with childhood trauma, sham stimulation group of depression patients with childhood trauma:true stimulation of Stanford Neuromodulation Therapy
sham stimulation group of depression patients with childhood trauma:sham stimulation of Stanford Neuromodulation Therapy
Depression group with childhood trauma:None
Depression group without childhood trauma:None
Healthy control group:None

Sponsors

Hebei Provincial Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Depression group: 1. Meeting the diagnostic criteria for depression in the Diagnostic and Statistical Manual of Mental Disorders (5th Edition), without psychotic symptoms, confirmed by two or more attending psychiatrists; 2. A score of >= 18 on the 17 - item Hamilton Depression Rating Scale (HAMD - 17); 3. Aged between 18 and 60 years, regardless of gender; 4. Right - handed. Healthy control group: 1. Aged between 18 and 60 years, regardless of gender; 2. A score of < 7 on the 17 - item Hamilton Depression Rating Scale (HAMD - 17); 3. Negative trauma results in all dimensions of the Childhood Trauma Questionnaire (CTQ - SF); 4. Right - handed.

Exclusion criteria

Exclusion criteria: Depression group: 1. Meeting the diagnostic criteria for other mental disorders in DSM - 5; 2. Having contraindications for MRI or rTMS; 3. Having a clearly diagnosed neurological disease, such as epilepsy; having comorbid organic brain diseases and a history of severe brain trauma; having severe or unstable physical diseases; 4. Having received rTMS, ECT or light therapy within three months; 5. Being ineffective to ECT treatment (> 8 times); 6. Having previously received antidepressant treatment with implanted devices (DBS, VNS); 7. Being pregnant or lactating women; 8. Having a significant suicide risk (the suicide score of item 3 in HAMD - 17 >= 3 points); 9. Having difficulty in verbal communication and being unable to cooperate with treatment and evaluation. Healthy control group: 1. Having a positive family history of mental illness; 2. Suffering from mental illness, neurological diseases, severe physical diseases, etc.; 3. Being pregnant or lactating women; 4. Having contraindications for magnetic resonance scanning, such as having a cardiac pacemaker.

Design outcomes

Primary

MeasureTime frame
Fractional Anisotropy (FA);

Secondary

MeasureTime frame
HAMD-17 score;

Countries

China

Contacts

Public ContactFan Ziqi

Hebei Provincial Mental Health Center

fanziqi0622@163.com+86 156 1341 9986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026